| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,292 |
2,832 |
$164K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
9,476 |
3,802 |
$85K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
6,194 |
2,805 |
$51K |
| 0134A |
|
33 |
16 |
$295.20 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
61 |
61 |
$205.24 |
| 86328 |
|
35 |
13 |
$45.28 |
| 0124A |
|
21 |
19 |
$36.90 |
| G0008 |
Administration of influenza virus vaccine |
24 |
24 |
$0.00 |
| 90686 |
|
23 |
23 |
$0.00 |
| 91313 |
|
33 |
16 |
$0.00 |
| 91312 |
|
21 |
19 |
$0.00 |